Treatment of diabetes mellitus after renal transplantation

Newark, DE US
January 9, 2020

This presentation will discuss complications associated with kidney transplant that include transient post-transplant hyperglycemia and post-transplant diabetes mellitus in order to provide the pharmacist tools to distinguish and diagnose between the two. Pharmacists will receive in-depth pathophysiology of the kidney and its role in glucose homeostasis. Additionally, pharmacists will be able to recognize and analyze common immunosuppressants used in kidney transplant that may induce hyperglycemia (e.g., glucocorticoids, calcineurin inhibitors, etc). By the end of this presentation, pharmacists will be able to recommend pharmacologic treatment options that are patient-specific for the kidney transplant population.

Target Audience

  • Pharmacists

Learning Objectives

  1. Identify post-transplantation diabetes mellitus (PTDM)
  2. Analyze the role immunosuppressants play in contributing to PTDM
  3. Recommend pharmacologic treatment options for patients presenting with PTDM
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
Course expires: 
Event starts: 
01/09/2020 - 12:00pm CST
Event ends: 
01/09/2020 - 1:00pm CST
ChristianaCare Hospital
4755 Ogletown-Stanton Rd.
Newark, DE 19713
United States

Relevant financial relationships: Nadia Hellenga (planning committee member) received a speaker honorarium from Veloxis Pharmaceuticals

Planning committee members
Sean Lasota, PharmD, BCACP
ChristianaCare Hospital
Nadia Hellenga, PharmD, BCPS
ChristianaCare Hospital
Julie Dally, PharmD, BCPS, BCACP
ChristianaCare Hospital
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Sumit Gandotra, PharmD
ChristianaCare Hospital

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare Hospital.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-021-L01-P
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance


Please login or register to take this course.